Notice of Intent To Grant an Exclusive License, 44617 [E7-15386]
Download as PDF
Federal Register / Vol. 72, No. 152 / Wednesday, August 8, 2007 / Notices
sroberts on PROD1PC70 with NOTICES
12 noon on October 16. The meeting is
open to the public.
The NAC consists of 59 national
organizations and advises the Secretary,
through the Under Secretary of Health,
on the coordination and promotion of
volunteer activities within VA health
care facilities. The Executive Committee
consists of 19 representations from the
NAC member organizations and acts as
the NAC governing body during the
period between NAC annual meetings.
On October 15, agenda topics will
include NAC goals and objectives, the
minutes of the May 2007 meeting, a
Veterans Health Administration update,
a VAVS update of the Voluntary Service
group’s progress, and emerging issues
since the May 2007 NAC annual
meeting. They will also include the
Parke Board update, evaluations of the
May 2007 annual meeting and plans for
2008 NAC annual meeting, to include
workshops and plenary sessions.
On October 16, agenda topics will
include 2009 NAC annual meeting
planning, recommendations, from the
May 2007 NAC annual meeting,
subcommittee reports, standard
operating procedure revisions, new
business and Executive Committee
appointments.
No time will be allocated at this
meeting for receiving oral presentations
from the public. However, interested
persons may either attend or file
statements with the Committee. Written
statements may be field either before the
meeting or within 10 days after the
meeting and addressed to: Ms. Laura
Balun, Designated Federal Officer,
Voluntary Service Office (10C2),
VerDate Aug<31>2005
19:14 Aug 07, 2007
Jkt 211001
Department of Veterans Affairs, 810
Vermont Avenue, NW., Washington, DC
20420. Ms Balun can be contacted by
phone at (202) 273–8952.
Dated: July 31, 2007.
By Direction of the Secretary.
E. Philip Riggins,
Committee Management Officer.
[FR Doc. 07–3854 Filed 8–7–07; 8:45 am]
BILLING CODE 8320–01–M
DEPARTMENT OF VETERANS
AFFAIRS
Notice of Intent To Grant an Exclusive
License
Department of Veterans Affairs,
Office of Research and Development.
AGENCY:
ACTION:
Notice of intent.
SUMMARY: Notice is hereby given that
the Department of Veterans Affairs,
Office of Research and Development,
intends to grant Preventative Nutrient
Company, Inc., Northridge, CA USA, an
exclusive license to practice the
following patent applications: U.S.
Patent 7,144,865 issued on December 5,
2006 entitled ‘‘Compositions and
Methods for Treating Obesity’’; U.S.
Patent Application 5,834,032 issued on
November 10, 1998 entitled
‘‘Compositions and Methods for
Treating Diabetes’’; and U.S. Provisional
Patent Application 60/892,785 filed on
March 2, 2007 entitled ‘‘Compositions
and Methods for Treating Alzheimer’s
Disease.’’
PO 00000
Frm 00135
Fmt 4703
Sfmt 4703
44617
Comments must be received
within fifteen (15) days from the date of
this published Notice.
ADDRESSES: Send comments to: Amy E.
Centanni, Director of Technology
Transfer, Department of Veterans
Affairs, Office of Research and
Development, Attn: 12TT 810 Vermont
Avenue, NW., Washington, DC 20420,
Telephone: (202) 254–0199; Facsimile:
(202) 254–0460; e-mail:
Amy.centanni@va.gov.
Copies of the published patent
applications may be obtained from the
U.S. Patent and Trademark Office at
https://www.uspto.gov.
SUPPLEMENTARY INFORMATION: It is in the
public interest to so license these
inventions as Preventative Nutrient
Company, Inc., submitted a complete
and sufficient application for a license.
The prospective exclusive license will
be royalty-bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR 404.7. The prospective
exclusive license may be granted unless,
within fifteen (15) days from the date of
this published Notice, the Department
of Veterans Affairs Office of Research
and Development receives written
evidence and argument which
establishes that the grant of the license
would not be consistent with the
requirements of 35 U.S.C. 209 and 37
CFR 404.7.
DATES:
Dated: August 1, 2007.
Gordon H. Mansfield,
Deputy Secretary of Veterans Affairs.
[FR Doc. E7–15386 Filed 8–7–07; 8:45 am]
BILLING CODE 8320–01–P
E:\FR\FM\08AUN1.SGM
08AUN1
Agencies
[Federal Register Volume 72, Number 152 (Wednesday, August 8, 2007)]
[Notices]
[Page 44617]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-15386]
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Notice of Intent To Grant an Exclusive License
AGENCY: Department of Veterans Affairs, Office of Research and
Development.
ACTION: Notice of intent.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the Department of Veterans
Affairs, Office of Research and Development, intends to grant
Preventative Nutrient Company, Inc., Northridge, CA USA, an exclusive
license to practice the following patent applications: U.S. Patent
7,144,865 issued on December 5, 2006 entitled ``Compositions and
Methods for Treating Obesity''; U.S. Patent Application 5,834,032
issued on November 10, 1998 entitled ``Compositions and Methods for
Treating Diabetes''; and U.S. Provisional Patent Application 60/892,785
filed on March 2, 2007 entitled ``Compositions and Methods for Treating
Alzheimer's Disease.''
DATES: Comments must be received within fifteen (15) days from the date
of this published Notice.
ADDRESSES: Send comments to: Amy E. Centanni, Director of Technology
Transfer, Department of Veterans Affairs, Office of Research and
Development, Attn: 12TT 810 Vermont Avenue, NW., Washington, DC 20420,
Telephone: (202) 254-0199; Facsimile: (202) 254-0460; e-mail:
Amy.centanni@va.gov.
Copies of the published patent applications may be obtained from
the U.S. Patent and Trademark Office at https://www.uspto.gov.
SUPPLEMENTARY INFORMATION: It is in the public interest to so license
these inventions as Preventative Nutrient Company, Inc., submitted a
complete and sufficient application for a license. The prospective
exclusive license will be royalty-bearing and will comply with the
terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective
exclusive license may be granted unless, within fifteen (15) days from
the date of this published Notice, the Department of Veterans Affairs
Office of Research and Development receives written evidence and
argument which establishes that the grant of the license would not be
consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.
Dated: August 1, 2007.
Gordon H. Mansfield,
Deputy Secretary of Veterans Affairs.
[FR Doc. E7-15386 Filed 8-7-07; 8:45 am]
BILLING CODE 8320-01-P